Lahore: BF Biosciences Limited has announced the appointment of Mr. Muhammad Shakeel Sadiq Jajja as an Independent Director on its Board, effective June 01, 2026. This appointment fills the casual vacancy created by the resignation of Mr. Naveed Kamran Baloch. The company disclosed this development in a report dated June 1, 2026.

Mr. Jajja, who holds a Ph.D. in Management specializing in Operations, is a Fulbright Post-Doctoral Scholar from Stanford University. He brings over two decades of experience in management, corporate governance, research, and corporate advisory services to the board. His appointment reflects the company’s commitment to strengthening its leadership team.

In addition to joining the Board, Mr. Jajja has been appointed as the Chairman of the HR & Remuneration Committee and a Member of the Audit Committee. These appointments also aim to fill the casual vacancies left by Mr. Baloch’s resignation, for the remainder of the current term.

According to information available from the Pakistan Stock Exchange (PSX), BF Biosciences Limited’s decision is part of its ongoing efforts to maintain effective corporate governance structures. The market will be observing how these changes impact the company’s strategic direction and governance practices.

The company has requested the dissemination of this information to the certificate holders of the exchange, ensuring transparent communication with its stakeholders.